Your browser doesn't support javascript.
loading
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Holicek, Peter; Truxova, Iva; Rakova, Jana; Salek, Cyril; Hensler, Michal; Kovar, Marek; Reinis, Milan; Mikyskova, Romana; Pasulka, Josef; Vosahlikova, Sarka; Remesova, Hana; Valentova, Iva; Lysak, Daniel; Holubova, Monika; Kaspar, Petr; Prochazka, Jan; Kasikova, Lenka; Spisek, Radek; Galluzzi, Lorenzo; Fucikova, Jitka.
Afiliação
  • Holicek P; Sotio Biotech, Prague, Czech Republic.
  • Truxova I; Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
  • Rakova J; Sotio Biotech, Prague, Czech Republic.
  • Salek C; Sotio Biotech, Prague, Czech Republic.
  • Hensler M; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Kovar M; Institute of Clinical and Experimental Hematology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Reinis M; Sotio Biotech, Prague, Czech Republic.
  • Mikyskova R; Laboratory of Tumor Immunology, Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic.
  • Pasulka J; Laboratory of Immunological and Tumour Models, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
  • Vosahlikova S; Laboratory of Immunological and Tumour Models, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
  • Remesova H; Sotio Biotech, Prague, Czech Republic.
  • Valentova I; Sotio Biotech, Prague, Czech Republic.
  • Lysak D; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Holubova M; Sotio Biotech, Prague, Czech Republic.
  • Kaspar P; Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic.
  • Prochazka J; Department of Hematology and Oncology, Faculty Hospital in Pilsen, Pilsen, Czech Republic.
  • Kasikova L; Biomedical Center, Medical Faculty in Pilsen, Charles University, Pilsen, Czech Republic.
  • Spisek R; Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
  • Galluzzi L; Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic.
  • Fucikova J; Sotio Biotech, Prague, Czech Republic.
Cell Death Dis ; 14(3): 209, 2023 03 24.
Article em En | MEDLINE | ID: mdl-36964168
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Interferon Tipo I / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Interferon Tipo I / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article